Y. Kakeji

413 total citations
18 papers, 317 citations indexed

About

Y. Kakeji is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Y. Kakeji has authored 18 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Y. Kakeji's work include Gastric Cancer Management and Outcomes (5 papers), Metastasis and carcinoma case studies (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Y. Kakeji is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Metastasis and carcinoma case studies (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Y. Kakeji collaborates with scholars based in Japan and United States. Y. Kakeji's co-authors include Eriko Tokunaga, Yoshihiko Maehara, Hideya Takeuchi, Keizo Sugimachi, Takashi Koga, K Sugimachi, Tamon Kusumoto, Daisuke Yoshida, Shunji Kohnoe and Shinichiro Yamaguchi and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Y. Kakeji

18 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Kakeji Japan 10 115 109 91 88 86 18 317
A Bali Belgium 5 89 0.8× 130 1.2× 90 1.0× 53 0.6× 58 0.7× 5 313
Keizo Sugimachi Japan 7 138 1.2× 136 1.2× 207 2.3× 144 1.6× 67 0.8× 10 421
Yatsushi Nishi Japan 9 48 0.4× 48 0.4× 44 0.5× 65 0.7× 67 0.8× 24 211
Mehdi Montazer Iran 13 76 0.7× 131 1.2× 46 0.5× 63 0.7× 163 1.9× 35 365
Maria del Carmen Sancho‐Serra Netherlands 6 54 0.5× 36 0.3× 56 0.6× 68 0.8× 46 0.5× 7 343
Gijs van Boxel United Kingdom 6 32 0.3× 44 0.4× 40 0.4× 97 1.1× 100 1.2× 12 277
S. Hatooka Japan 7 130 1.1× 82 0.8× 51 0.6× 15 0.2× 233 2.7× 11 395
Eugenijus Stratilatovas Lithuania 11 154 1.3× 136 1.2× 115 1.3× 18 0.2× 45 0.5× 33 320
Liang Zhuang China 12 40 0.3× 144 1.3× 55 0.6× 33 0.4× 188 2.2× 28 398
Osmel Companioni Spain 9 51 0.4× 49 0.4× 23 0.3× 48 0.5× 105 1.2× 18 255

Countries citing papers authored by Y. Kakeji

Since Specialization
Citations

This map shows the geographic impact of Y. Kakeji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Kakeji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Kakeji more than expected).

Fields of papers citing papers by Y. Kakeji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Kakeji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Kakeji. The network helps show where Y. Kakeji may publish in the future.

Co-authorship network of co-authors of Y. Kakeji

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Kakeji. A scholar is included among the top collaborators of Y. Kakeji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Kakeji. Y. Kakeji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kondo, Ken, Sotaro Sadahiro, Takashi Tsuchiya, et al.. (2012). Phase III Trial of Treatment Duration for Oral Uracil and Tegaful/Leukovorin Adjuvant Chemotherapy for Patients (PTS) with Stage IIB/III Colon Cancer: Result of JFMC33-0502. Annals of Oncology. 23. ix188–ix188. 3 indexed citations
2.
Oki, Eiji, Koji Ando, Hideyuki Saeki, et al.. (2011). Prognostic significance of mortalin expresion in gastric adenocarcinoma with wild-type p53.. Journal of Clinical Oncology. 29(15_suppl). e14662–e14662. 2 indexed citations
3.
Hisamatsu, Yosuke, Eriko Tokunaga, Sayuri Akiyoshi, et al.. (2011). The expression of GATA-3 and FOXA1 in breast cancer: The biomarkers of hormone sensitivity in luminal-type tumors.. Journal of Clinical Oncology. 29(15_suppl). 599–599. 3 indexed citations
4.
Oki, Eiji, Y. Kakeji, Makoto Morita, et al.. (2010). Transient elastography for the assessment of oxaliplatin-associated liver damage in colon cancer patients with liver metastasis.. Journal of Clinical Oncology. 28(15_suppl). e14088–e14088. 1 indexed citations
5.
Emi, Yasunori, H Orita, Michiko Yamamoto, et al.. (2009). 6536 Feasibility of adjuvant S-1 plus docetaxel against stage II-III gastric cancer following R0 resection in gastrectomy. European Journal of Cancer Supplements. 7(2). 372–372. 2 indexed citations
6.
Nagano, Jun, Suminori Kono, Kengo Toyomura, et al.. (2008). Personality and Colorectal Cancer: The Fukuoka Colorectal Cancer Study. Japanese Journal of Clinical Oncology. 38(8). 553–561. 9 indexed citations
7.
Yoshida, Daisuke, Suminori Kono, Malcolm A Moore, et al.. (2007). Colorectal Polypectomy and Risk of Colorectal Cancer by Subsite: The Fukuoka Colorectal Cancer Study. Japanese Journal of Clinical Oncology. 37(8). 597–602. 11 indexed citations
8.
Kakeji, Y., Shinichiro Yamaguchi, Daisuke Yoshida, et al.. (2006). Development and assessment of morphologic criteria for diagnosing gastric cancer using confocal endomicroscopy: an ex vivo and in vivo study. Endoscopy. 38(9). 886–890. 66 indexed citations
9.
Yasunaga, Tomohide, Makoto Hashizume, Y. Kakeji, et al.. (2004). Sixty endoscopic procedures assisted by remote-controlled laparoscope manipulator system, Naviot®, for endoscopic surgery. International Congress Series. 1268. 1314–1314. 2 indexed citations
10.
Takeuchi, Hideya, Yoshihiko Maehara, Eriko Tokunaga, et al.. (2003). Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma.. PubMed. 50(49). 289–92. 3 indexed citations
11.
Takeuchi, Hideya, et al.. (2001). Prognostic Significance of Natural Killer Cell Activity in Patients With Gastric Carcinoma: A Multivariate Analysis. The American Journal of Gastroenterology. 96(2). 574–578. 93 indexed citations
12.
Kakeji, Y., Y. Maehara, Tomohiro Koga, et al.. (2001). Gastric cancer with high telomerase activity shows rapid development and invasiveness.. Oncology Reports. 8(1). 107–10. 19 indexed citations
13.
Kakeji, Y., et al.. (1997). Lisofylline as an adjuvant to high dose cytotoxic therapy. International Journal of Oncology. 11(2). 265–72. 2 indexed citations
14.
Kakeji, Y., Yoshihiko Maehara, Masaru Morita, et al.. (1995). Correlation between sialyl Tn antigen and lymphatic metastasis in patients with Borrmann type IV gastric carcinoma. British Journal of Cancer. 71(1). 191–195. 30 indexed citations
15.
Takahashi, I., Yoshihiko Maehara, Tamon Kusumoto, et al.. (1994). Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients. British Journal of Cancer. 69(1). 163–166. 19 indexed citations
16.
Maehara, Yoshihiko, Akihiro Watanabe, Y. Kakeji, et al.. (1992). Prognosis for surgically treated gastric cancer patients is poorer for women than men in all patients under age 50. British Journal of Cancer. 65(3). 417–420. 19 indexed citations
17.
Mori, Masaki, Y. Kakeji, Yosuke Adachi, Daisuke Korenaga, & K Sugimachi. (1992). Non-polypoid inflammatory fibroid polyps concomitant with early carcinoma in the stomach.. PubMed. 18(6). 632–5. 10 indexed citations
18.
Maehara, Yoshihiko, Yasunori Emi, Tamon Kusumoto, et al.. (1990). Estrogen-Receptor-Negative Breast Cancer Tissue Is Chemosensitive in vitro Compared with Estrogen-Receptor-Positive Tissue. European Surgical Research. 22(1). 50–56. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026